Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Bangladesh · Delayed Price · Currency is BDT

21.30

+0.50 (2.40%)

At close: Jun 16, 2026

51.06% (1Y)

Market Cap	2.16B +45.5%
Revenue (ttm)	408.71M -4.6%
Net Income	34.23M -26.5%
EPS	0.33 -26.7%
Shares Out	103.81M
PE Ratio	62.86
Forward PE	n/a
Dividend	0.11 (0.53%)
Ex-Dividend Date	Dec 17, 2025

Volume	2,176,007
Open	n/a
Previous Close	20.80
Day's Range	20.60 - 21.40
52-Week Range	11.10 - 22.60
Beta	0.25
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 8, 2026

About Silco Pharmaceuticals

Silco Pharmaceuticals Limited engages in manufacturing and marketing of finished pharmaceutical products in Bangladesh and internationally. It offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxat... [Read more]

Industry Pharmaceutical Preparations

Founded 1995

Employees 313

Stock Exchange Dhaka Stock Exchange

Ticker Symbol SILCOPHL

Full Company Profile

Financial Performance

In fiscal year 2025, Silco Pharmaceuticals's revenue was 431.54 million, an increase of 5.23% compared to the previous year's 410.10 million. Earnings were 42.65 million, a decrease of -7.04%.

Financial Statements